who invented glp 1 drugs Scientists Pioneered GLP-1 Bag Breakthrough Prize How do GLP-1 agonists affect

Early trials, concerned about possible cardiac safety issues, were designed to ensure that GLP-1 use did not negatively impact cardiovascular outcomes

GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys

, Owens, A

Semaglutide , as a weekly injection, is sold as Ozempic for Type 2 diabetes and Wegovy for obesity the same molecule at slightly different doses

The future oral GLP-1 receptor agonists, incretin dual agonists, triple agonists, and other new oral metabolic products will become popular only if they prove themselves capable of producing sustained results in obesity disease, type 2 diabetes, hypertension, dyslipidemia, cardiovascular risks, and metabolic syndromes through their effectiveness and safety